View on Pubmed.gov 26939933 | View on doi.org 10.1186/s13024-...
The NLRP3 and NLRP1 inflammasomes are activated in Alzheimer's disease.
- Don C. Gnocchi Foundation, IRCCS, Piazza Morandi, 3, 20121, Milan, Italy. msaresella@dongnocchi.it.
- Don C. Gnocchi Foundation, IRCCS, Piazza Morandi, 3, 20121, Milan, Italy. flarosa@dongnocchi.it.
- Don C. Gnocchi Foundation, IRCCS, Piazza Morandi, 3, 20121, Milan, Italy. fpiancone@dongnocchi.it.
- Don C. Gnocchi Foundation, IRCCS, Piazza Morandi, 3, 20121, Milan, Italy. mzoppis@dongnocchi.it.
- Don C. Gnocchi Foundation, IRCCS, Piazza Morandi, 3, 20121, Milan, Italy. imarventano@dongnocchi.it.
- Don C. Gnocchi Foundation, IRCCS, Piazza Morandi, 3, 20121, Milan, Italy. ecalabrese@dongnocchi.it.
- Departments of Biomedical and Clinical Sciences "Luigi Sacco", University of Milano, 20100, Milan, Italy. veronica.rainone@unimi.it.
- Don C. Gnocchi Foundation, IRCCS, Piazza Morandi, 3, 20121, Milan, Italy. rnemni@dongnocchi.it.
- Departments of Physiopathology and Transplants, University of Milano, 20100, Milan, Italy. rnemni@dongnocchi.it.
- Don C. Gnocchi Foundation, IRCCS, Piazza Morandi, 3, 20121, Milan, Italy. rmancuso@dongnocchi.it.
- Don C. Gnocchi Foundation, IRCCS, Piazza Morandi, 3, 20121, Milan, Italy. mario.clerici@unimi.it.
- Departments of Physiopathology and Transplants, University of Milano, 20100, Milan, Italy. mario.clerici@unimi.it.
Abstract
BACKGROUND
Interleukin-1 beta (IL-1β) and its key regulator, the inflammasome, are suspected to play a role in the neuroinflammation observed in Alzheimer's disease (AD); no conclusive data are nevertheless available in AD patients.
RESULTS
mRNA for inflammasome components (NLRP1, NLRP3, PYCARD, caspase 1, 5 and 8) and downstream effectors (IL-1β, IL-18) was up-regulated in severe and MILD AD. Monocytes co-expressing NLRP3 with caspase 1 or caspase 8 were significantly increased in severe AD alone, whereas those co-expressing NLRP1 and NLRP3 with PYCARD were augmented in both severe and MILD AD. Activation of the NLRP1 and NLRP3 inflammasomes in AD was confirmed by confocal microscopy proteins co-localization and by the significantly higher amounts of the pro-inflammatory cytokines IL-1β and IL-18 being produced by monocytes. In MCI, the expression of NLRP3, but not the one of PYCARD or caspase 1 was increased, indicating that functional inflammasomes are not assembled in these individuals: this was confirmed by lack of co-localization and of proinflammatory cytokines production.
CONCLUSIONS
The activation of at least two different inflammasome complexes explains AD-associated neuroinflammation. Strategies targeting inflammasome activation could be useful in the therapy of AD.
References
J Microsc. 2006 Dec;224(Pt 3):213-32
J Am Soc Nephrol. 2012 Nov;23(11):1783-9
J Neuroinflammation. 2006 Mar 16;3:5
Nat Immunol. 2015 Mar;16(3):229-36
Cited by 415 citations (total)
Journal Article Research Support, N.I.H., Extramural
NLRP3 inflammasome as a novel target for docosahexaenoic acid metabolites to abrogate glomerular injury.
Electronic publication date January 16, 2018
Guangbi Li [...] Pin-Lan Li et al.
The nucleotide-binding oligomerization domain-like receptor containing pyrin domain 3 (NLRP3) inflammasome has been implicated in podocyte injury and glomerular sclerosis...
Journal Article Review
The Role of the Effects of Autophagy on NLRP3 Inflammasome in Inflammatory Nervous System Diseases.
Electronic publication date June 4, 2021
Shizhen Zhao [...] Honggang Wang et al.
Autophagy is a stable self-sustaining process in eukaryotic cells. In this process, pathogens, abnormal proteins, and organelles are encapsulated by...
Conflict of interest statement
MeSH
- •
- •
- •
- •
- •
- •
Specialties
- •
- •
- •
- •
- •
Substances
- •
- •
- •
- •
- •
- •
- •
- •
- •